Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
80%(8 trials)

Phase Distribution

Ph phase_4
2
20%
Ph not_applicable
7
70%
Ph phase_2
1
10%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
1(10.0%)
Phase 4Post-market surveillance
2(20.0%)
N/ANon-phased studies
7(70.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(10)

Detailed Status

Completed10

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (10.0%)
Phase 42 (20.0%)
N/A7 (70.0%)

Trials by Status

completed10100%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DEVICE
Total Trials
10